Home >Stock channel > text
The first regulatory ticket for the Year of the Pig! Zhang Jianping’s family violated regulations and increased the holding of Haili’s biological punishment.
Brokerage China Come True
The first regulatory ticket after the Spring Festival was given to three cows!
February 10,HaleyAnnouncement, the company recently received a decision on the administrative supervision measures of the CSRC. This regulatory ticket was issued to three cattle:
From October 18, 2018 to November 1, 2018, Zhang Jianping, Fang Wenyan and Fang Deji continued to increase the shareholding of Haili Biotech through 34,452,615 shares through the stock exchange of the stock exchange, accounting for 5.37% of the total share capital of Haley. The above acts violated the relevant regulations and decided to take administrative supervision measures on Zhang Jianping, Fang Wenyan and Fang Deji.
According to the announcement of the latest changes in the rights and interests of Haley Biotech, as of the close of January 8, 2019, Zhang Jianping and his concerted activists increased their shareholding in Haili Bio with their own funds through block trades and concentrated bidding transactions, reaching 98,987,290 shares. The total share capital of Haley Bio is 15.3707%.
It is worth noting that since Haili Biotechnology released its shareholding plan on October 17 last year, the time interval was less than three months on January 8, 2019. Zhang Jianping and his concerted actioners increased their shareholdings by 66,780,500 shares, costing close to 9. Billion yuan, the buying speed is really amazing.
Super Niu Zhang Jianping's massive sweeping of goods, let Haili Bio's share price rise against the market, the stock price rose from around 7 yuan in late September to around 15 yuan in early November, in just three months, the stock price has doubled.
For investors, the three names of Zhang Jianping, Fang Wenyan and Fang Deji are no strangers, and they are all super-bullish in the A-share market. As of the third quarter of last year, Zhang Jianping holdsLetv,Kangtai BioAnd Haley Bio, which was previously heldBOE A,Dream Boat,Duolun Technology,Ritter,Zhejiang Dongri,Oriental wealth,Tourist network,Borui CommunicationEtc; Fang Deji also heldZTE,Nachuan shares,Junzheng Group,Zhao Yi Innovation, Duolun Technology, Rielt,Fu Lin Seiko,Asian Development,Total electroacoustic,Financial developmentWait.
Spring Festival's first regulatory ticket
On February 10th, Haili Bio announced that the company recently received the decision of the Shanghai Securities Regulatory Commission of the China Securities Regulatory Commission on the Administrative Supervision Measures (the decision on issuing warning letters to Zhang Jianping, Fang Wenyan and Fang Deji) (Shanghai Securities Commission [ 2019] No. 12). The Decision Book mentions:
After investigation, Zhang Jianping, Fang Wenyan and Fang Deji acted as concerted actors. As of October 15, 2018, they held a total of 32,204,794 shares of Haley Bio-stock, accounting for 5.0007% of the total share capital of Haley Bio.
From October 18, 2018 to November 1, 2018, Zhang Jianping, Fang Wenyan and Fang Deji continued to increase the shareholding of Haili Biotech through 34,452,615 shares through the stock exchange of the stock exchange, accounting for 5.37% of the total share capital of Haley.
Zhang Jianping, Fang Wenyan, and Fang Deji violated the provisions of Article 13, paragraph 2, of the Measures for the Administration of the Acquisition of Listed Companies (Order No. 108 of the CSRC). According to the provisions of Article 75 of the Measures for the Administration of the Acquisition of Listed Companies, it was decided to adopt administrative supervision measures for Zhang Jianping, Fang Wenyan and Fang Deji to issue warning letters.
Article 13 (2) of the Measures for the Administration of the Acquisition of Listed Companies stipulates that the shares in which the investors and their concerted parties have interests reach 5% of the issued shares of a listed company, and they own the securities through the stock exchange. Each time the share of the equity shares accounts for 5% of the issued shares of the listed company, it shall be reported and announced in accordance with the provisions of the preceding paragraph. During the reporting period and within 2 days after the report or announcement, the shares of the listed company may not be traded.
According to public information, Haley Bio is a specialized veterinary biological product manufacturer integrating R&D, production, sales and service. The business scope includes the production of live veterinary vaccines, inactivated vaccines, animal serum and animal products, sales of self-produced products of the company; related technology transfer, technical services; breeding equipment (limited to poultry and livestock breeding machinery), veterinary equipment, feed additives , veterinary drugs, import and export, wholesale and related raw and auxiliary materials; agricultural and sideline products acquisition (except rice, corn, wheat).
Three cattle scattered tickets
According to the "Decision Book", Zhang Jianping, Fang Wenyan and Fang Deji violated the provisions of Article 13 (2) of the Measures for the Administration of the Acquisition of Listed Companies (Order No. 108 of the CSRC). According to the provisions of Article 75 of the Measures for the Administration of the Acquisition of Listed Companies, the Shanghai Securities Regulatory Bureau decided to take administrative supervision measures on Zhang Jianping, Fang Wenyan and Fang Deji.
According to the previous announcement information, Zhang Jianping, Fang Wenyan, and Fang Deji were three "singles". Mr. Zhang Jianping and Ms. Fang Wenyan are husband and wife relations. Ms. Fang Wenyan and Mr. Fang Deji are fathers and daughters. Mr. Fang Zhangle is the son of Mr. Zhang Jianping and Ms. Fang Wenyan.
The "Decision Book" mentions that if you are dissatisfied with this supervision and management measure, you may file an application for administrative reconsideration with the China Securities Regulatory Commission within 60 days from the date of receipt of this decision, or from the date of receipt of this decision. Within one month, file a lawsuit in a people's court with jurisdiction. During the reconsideration and litigation, the above supervision and management measures will not be suspended.All the way to high-profile increase in holdings behind the suspicion
Judging from the changes in the top ten shareholders of Haley Biotechnology, Zhang Jianping appeared in the list of the top ten shareholders for the first time in the semi-annual report of 2018.
In early February 2018, Haley Biological suspended its plan to acquire assets and resumed trading in early April. This incident became a watershed in the stock market and trend of Haili Bio. After the resumption of trading in early April last year, the trading volume of Haley Biotech was significantly enlarged, and the stock price was all the way up.
On October 17, last year, Haley Biotech issued the "Announcement on Shareholders' Plan to Increase Shareholding in the Company". Shareholder Zhang Jianping and his concerted actions Fang Wenyan and Fang Deji plan to pass Shanghai Securities within the next 12 months from October 17, 2018. The exchange trading system will increase the holdings of the company's shares. The proposed holding amount is not less than 20 million yuan, not more than 400 million yuan. The holding price will be determined based on the fluctuation of stock prices and the overall trend of the capital market.
According to the latest data, as of the close of January 8, 2019, Zhang Jianping and his concerted activists increased their shareholding in Haili Bio with their own funds through block trading and centralized bidding, reaching 98,987,290 shares, accounting for the total share capital of Haley Bio. 15.3707%.
This also means that since Haili Biotech released an increase plan, by January 8, 2019, the time interval was less than three months. Zhang Jianping and his concerted actions increased the number of 66.78 million shares, costing nearly 900 million yuan, buying The speed is amazing. The share price of Haley Bio has risen from around 7 yuan in late September to around 15 yuan in early November. In just three months, the stock price has doubled.
In addition, the public information shows that Haili No. 1, which was subscribed by Haili Bio's first employee stock ownership plan, has sold its total of 12.03 million shares of the listed company during the period from July 1 to 26 last year. It is worth noting that the cost price of the employee stock ownership plan is 16.53 yuan per share, and it has also made a 1:1 leveraged fund, which cost nearly 1.9 billion yuan. From the perspective of the reduction period, it should be a loss, and it is precisely before the market launch, the part of the shareholding plan has been cleared.
Three super cattle scattered "叱咤" A shares
For investors, the three names of Zhang Jianping, Fang Wenyan and Fang Deji are no strangers, and they are all super-bullish in the A-share market.
According to the statistics of Chinese authors of brokerages, as of the third quarter of last year, Zhang Jianping broke into the top ten shareholders of LeTV, Kangtai Bio and Haili Bio. Previous data showed that Zhang Jianping also entered the top ten shareholders of BOE A, Dream Boat, Duolun Technology, Reiter, Zhejiang Dongri, Oriental Fortune, Youzu Network, and Borui Communication.
As of the third quarter of last year, Fang Deji only holds Kangtai Bio. Previous data showed that Fang Deji also entered ZTE, Nachuan, Junzheng Group, Zhaoyi Innovation, Duolun Technology, Reiter, Fulin Seiko, Yalian Development, A total of electro-acoustic, financial development and other stocks Ten major shareholders.
Fang Wenyan has been relatively "low-key" in recent years, and has not appeared in the top ten shareholders of listed companies since the third quarter of 2017. Previously held Dream Boat, Duolun Technology, Reiter,Halo New Network,Pubang sharesWait for stocks.
Editor in charge: Robot RF13015
- Tonghuashun cloud software receives regulatory notices, and employees provide violations of regulations.
- Violation of securities brokers frequently eat regulatory fines
- Was fined 1.2 million! Changshan Pharmaceutical, which says Chinese man "ED", received a regulatory ticket
- Western Securities one-and-a-half-year seven-year regulatory fines Operating cash flow three-year net outflows nearly 10 billion
- Three-year operating cash flow net outflow of nearly 10 billion Western Securities within seven and a half within seven years of regulatory fines
Must not look
888.8 billion! A shares sent the biggest start "profit is"02-11 22:24
Important announcement of the listed company on Monday02-11 18:00
A-share headline: Tongzhou will integrate planning with Langfang North Three Counties02-12 05:37
Negative: US companies apply for a 337 investigation into Yongan Pharmaceutical Taurine products02-11 17:51
The stock market soared on the "News Network" "Golden Pig" market is not general02-12 06:41
Daily limit forecast on February 12: 5 shares are expected to stand out02-12 07:05
Capital surges to oversold stocks Focus on small and medium-sized market segments (schedule)02-12 06:43
Flexible screen clothing into the spring evening network red flexible screen market began to break out (beneficiary shares)02-12 06:48
Infrastructure investment will be overweight "new infrastructure" will drive market demand in communications and other industries02-12 05:52
MSCI: Incorporating Industrial Fulian, US Mission Review and Xiaomi into Emerging Markets Index02-12 06:20